WHO ICTRP trial
To study the effect of duralabhadi kashaya ghanvati and levofloxacin in urinary…
CTRI/2023/10/058212 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2023/10/058212 |
|---|---|
| Public title | To study the effect of duralabhadi kashaya ghanvati and levofloxacin in urinary tract infection |
| Scientific title | In-vitro and Clinical evaluation of Duralabhadi kashaya ghanvati in comparison with Levofloxacin in the management of Mutrakrichha w.s.r to Urinary tract infection - NIL |
| Primary sponsor | Parul Institute of ayurved |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: N390- Urinary tract infection, site notspecified |
| Registration date | Mar 10, 2023 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: